Property based optimisation of glucokinase activators – discovery of the phase IIb clinical candidate AZD1656

Michael J. Waring, David S. Clarke, Mark D. Fenwick, Linda Godfrey, Sam D. Groombridge, Craig Johnstone, Darren McKerrecher, Kurt G. Pike, John W. Rayner, Graeme R. Robb, Ingrid Wilson
  • MedChemComm, January 2012, Royal Society of Chemistry
  • DOI: 10.1039/c2md20077e
The author haven't yet claimed this publicationThe author haven't yet claimed this publication

In partnership with: